Arthritis Drugs Archive | 2006

Arthritis Drugs

Litigation Watch: ARTHRITIS DRUGS is a monthly newsletter for attorneys, focusing on drugs used to treat osteo and rheumatoid arthritis: Arava, Enbrel, Remicade, Humira, Vioxx, Celebrex and more. These drugs are already the subject of litigation following claims that they cause everything from liver damage to cancer, heart failure and strokes. Each issue features case news, interviews, legislative and FDA updates, and reviews from current medical literature.


Arthritis Drugs - Issue: 24

Jurors Add $9 Million Punitive Award to Vioxx Plaintiff's $4.5 Million Verdict

Read Full Article



Arthritis Drugs - Issue: 23

Vioxx Distributors Maintain No Liability for Failure to Warn

Read Full Article

Merck: Foreign Vioxx Class Actions Belong in Home Jurisdictions, Not MDL

Read Full Article

N.J. Jury Enters Split Verdict in First 'Long-Term Use' Vioxx Trial

Read Full Article

PSC Seeks Remand Procedure to Improve Vioxx MDL Trial Efficiency

Read Full Article

Plaintiffs Say Vioxx Distributors Legally Liable for Failure to Warn

Read Full Article

Court Affirms Vioxx Third-Party Payor Class Certification

Read Full Article



Arthritis Drugs - Issue: 22

Arthritis Drugs in the Medical Literature This Month - March 2006

Read Full Article




ISSUES BY YEAR




The HarrisMartin VerdicTrack



The HarrisMartin VerdicTrack lets you track verdicts by product, state, defendant, or expert.